Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.7.1.2 (
nitrate reductase
)
3,861
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Previously, it has been shown that treatment of Paracoccus denitrificans cells with phenylglyoxal inhibits the methyl-viologen-linked
nitrate reductase
activity by blocking the nitrate transporter. This inhibition disappears if tetraphenylphosphonium cation (
TPP
(+)) is added to the assay medium. In the present paper, the following evidence suggests that the effect of
TPP
(+) results from an increased transmembrane anion permeability and not from transporter reactivation or cell lysis. (1) Beside nitrate,
TPP
(+) also mediated the utilisation of chlorate, which normally lacks access to the cytoplasm. (2) The
TPP
(+) pathway had about hundred-times higher K(m) values for nitrate and chlorate than
nitrate reductase
in Triton X-100 permeabilised cells. (3) Although the uncoupler CCCP alone failed to overcome the PG block, it stimulated the operation of the
TPP
(+) pathway. (4) The method of continuous variations allowed the transport stoichiometry
TPP
(+)/NO(3)(-) to be determined as 3, indicating charge compensation for nitrate movement and the subsequent transmembrane two-electron redox reaction. Anion uptake was also measured independently from passive swelling of uncoupled spheroplasts in iso-osmotic solutions of ammonium salts. The permeability to nitrate lay in the permeability sequence Cl(-)<NO(3)(-)<ClO(4)(-)<SCN(-) and was further enhanced by
TPP
(+).
...
PMID:Passive penetration of nitrate through the plasma membrane of Paracoccus denitrificans and its potentiation by the lipophilic tetraphenylphosphonium cation. 1261 55